Junhemeng Biopharmaceutical

Junhemeng Biopharmaceutical

A recombinant protein drug developer.

Launch date
Employees
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Sep 2024.)
小营街道 Zhejiang (HQ)
  • Edit
DateInvestorsAmountRound
*

CNY100m

Series B
*

CNY200m

Series B
Total Funding€37.5m

Recent News about Junhemeng Biopharmaceutical

Edit